These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 18807231
41. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
42. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Granlund D. Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322 [Abstract] [Full Text] [Related]
43. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE. Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636 [Abstract] [Full Text] [Related]
45. The practice of splitting tablets: cost and therapeutic aspects. Bachynsky J, Wiens C, Melnychuk K. Pharmacoeconomics; 2002 Oct; 20(5):339-46. PubMed ID: 11994043 [Abstract] [Full Text] [Related]
46. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Health Policy; 2007 Aug; 82(3):366-74. PubMed ID: 17141355 [Abstract] [Full Text] [Related]
47. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting. Lamarque V, Merle L, Demarez JP, Round Table No. 7, Giens XXIII. Therapie; 2008 Aug; 63(4):301-9. PubMed ID: 18937910 [Abstract] [Full Text] [Related]
48. Generic prescribing in Pennsylvania. Hayes AH. Pa Med; 1977 Mar; 80(3):28-9. PubMed ID: 846745 [No Abstract] [Full Text] [Related]
59. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets. Fahelelbom KM, Al-Tabakha MM, Eissa NA, Javadi J. Sci Pharm; 2016 Oct 11; 84(4):646-653. PubMed ID: 27727195 [Abstract] [Full Text] [Related]
60. Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons. Gradl G, Krieg EM, Schulz M. Pharm Pract (Granada); 2016 Oct 11; 14(3):786. PubMed ID: 27785166 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]